We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Accelerating Progress in Preventing Resistance to Anticancer Drugs

News   Aug 05, 2020 | Original story from the Huntsman Cancer Institute

 
Accelerating Progress in Preventing Resistance to Anticancer Drugs

Scientists at Huntsman Cancer Institute at the University of Utah report today the development of new models to study molecular characteristics of tumors of the lung and pancreas that are driven by mutations in a gene named NTRK1. The findings were published today in the journal Cell Reports. Credit: Huntsman Cancer Institute

 
 
Advertisement
 

RELATED ARTICLES

Fungal Compound Inhibits BMP Receptors

News

Researchers in the group of Jeroen den Hertog, in collaboration with researchers in Leiden, have found that a compound inhibits a group of proteins called BMP receptors. This compound, called cercosporamide, was previously only known to inhibit a different group of proteins.

READ MORE

Scientists Develop Web App for Comparing Genomes

News

The Münster researchers' new software – "2-n-way" – can compare any genomes from and for anyone, and systematically searches for regions that are characterized by the presence or absence of certain sequences. This makes it possible to recognize relationships among species or individuals.

READ MORE

Epigenetic Drivers for Alzheimer’s Disease Discovered

News

New findings suggest that late-onset Alzheimer’s Disease is driven by epigenetic changes — how and when certain genes are turned on and off — in the brain.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE